INTEGRAL ACQUISITION CORP 1 C/WTS 31/05/2028 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -0.17
I'm LongbridgeAI, I can summarize articles.EPS: As of FY2025 Q1, the actual value is USD -0.17.
Segment Revenue
- The company has not generated any operating revenues as of March 31, 2025, and will not generate any until after the completion of its initial Business Combination.
Operational Metrics
- Net Loss: For the three months ended March 31, 2025, the net loss was $563,289, compared to $260,035 for the same period in 2024.
- Operating Costs: Operating costs increased to $588,285 for the three months ended March 31, 2025, from $385,411 for the same period in 2024.
- Interest Income: Interest income from the Trust Account was $36,338 for the three months ended March 31, 2025, compared to $169,451 for the same period in 2024.
Cash Flow
- Net Cash Used in Operating Activities: For the three months ended March 31, 2025, net cash used in operating activities was - $348,475, compared to - $292,306 for the same period in 2024.
- Net Cash Provided by Investing Activities: Net cash provided by investing activities was $22,411 for the three months ended March 31, 2025, compared to - $89,876 for the same period in 2024.
- Net Cash Provided by Financing Activities: Net cash provided by financing activities was $260,640 for the three months ended March 31, 2025, compared to $375,000 for the same period in 2024.
Unique Metrics
- Cash Held in Trust Account: As of March 31, 2025, cash held in the Trust Account was $4,091,931, compared to $4,078,045 as of December 31, 2024.
Future Outlook and Strategy
- Core Business Focus: The company is focused on completing its initial Business Combination within the extended Combination Period ending November 5, 2025. The company has entered into the Flybondi Business Combination Agreement, which involves merging with Merger Sub and becoming a wholly-owned subsidiary of FB Parent.
- Non-Core Business: The company has extended its Combination Period multiple times and may seek further extensions consistent with applicable laws and regulations. The company is also addressing compliance issues related to its listing on Nasdaq and has transitioned to trading on the OTC Pink Market.
Priority
- The company is prioritizing the completion of the Flybondi Business Combination, which has been amended to extend the Agreement End Date to April 30, 2025.
